Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly
{{output}}
Discovering the brakes/checkpoints that cancer places on the immune system to prevent being eradicated led to the 2018 Nobel Prize and the development of multiple Food and Drug Administration-approved immune checkpoint inhibitors (ICIs). ICIs have transformed ... ...
